Problems in the Diagnosis and Treatment of Invasive Fungal Infections: Recent Advances in Their Management, ESCMID Postgraduate Education Course
2 - 3 March 2012, Athens, Greece
- Hellenic Society of Medical Mycology (HSMM)
- ESCMID Fungal Infection Study Group (EFISG)
- 4th Department of Internal Medicine, National Kapodistrian University of Athens
The course will provide an update on epidemiology, diagnosis and treatment of invasive fungal infections. It puts emphasis on host characteristics in various groups, such as patients with neutropenia, stem cell transplantation, solid organ transplantation, HIV, iron overload, trauma, etc.
Royal Olympic Hotel
28-34 Ath. Diakou
Athens 117 43
Up to 120 infectious disease specialists, clinical microbiologists, mycologists, hematologists, intensivists and PhD students.
Presentations are availabe in the ESCMID Online Lecture Library.
Friday, 2 March 2012
14.00 – 15.30 Changing epidemiology of invasive fungal infections
- Emerging pathogens
16.00 – 18.00 Problems and progress in the diagnosis of IFIs
- When should the clinician suspect the presence of IFI?
- Early diagnosis with the aid of serological markers
- Molecular methods in the diagnosis of IFIs: How far have we advanced?
- Definitive diagnosis of invasive fungal infections: an elusive target
18.00 –18.45 Correlation of in vitro susceptibility to clinical outcome
Saturday, 3 March 2012
09.00 –10.30 Problems in treatment arising from the fungus
- Treatment of IFIs due to resistant strains of Aspergillus
- Treatment of IFIs due to Scedosporium and Fusarium species
- Treatment of IFIs due to Cryptococcus
- Treatment of IFIs due to Mucorales
10.30 –12.00 Difficult to treat IFIs
- Fungal endocarditis
- Fungal infections of the CNS
- Osteoarticular fungal infections
12.30 –14.00 Problems in treatment due to altered PK/PD
- Azoles: Are we under-treating our patient?
- Dosing of antifungals in patients with renal or hepatic failure
- PK/PD of antifungals in neonates and infants
15.00 –16.30 Recent advances in the treatment of IFIs
- Activities of newer antifungals against Candida biofilms
- Combination of antifungals: an update
- Newer antifungals: what’s in the pipeline
16.30 –18.00 Patients at high risk of invasive fungal infections: when and how to treat
- Candida prophylaxis in critically ill patients
- Aspergillus sp. in bronchial secretions of ICU patients: when should we treat?
- Febrile neutropenia: pre-emptive or targeted treatment?
18.00 – 19.00 Interactive case presentations
19.00 Closing remarks
- Anastasia Antoniadou, Athens, Greece
- Oliver Cornely, Cologne, Germany
- Manuel Cuenca-Estrella, Madrid, Spain
- George Daikos, Athens, Greece
- Miranda Drogari-Apiranthitou, Athens, Greece
- Andreas Groll, Muenster, Germany
- Lene Klingspor, Stockholm, Sweden
- Olivier Lortholary, Paris, France
- Joseph Meletiadis, Athens, Greece
- Patricia Muñoz, Madrid, Spain
- Livio Pagano, Rome, Italy
- George Petrikkos, Athens, Greece
- Juan Luis Rodriguez-Tudela, Majadahonda, Spain
- Emmanuel Roilides, Thessaloniki, Greece
- Helen Sabatakou, Athens, Greece
- George Samonis, Heraklion, Greece
- Anna Skiada, Athens, Greece
- Sotirios Tsiodras, Athens, Greece
- Paul Verweij, Nijmegen, The Netherlands
- Georgia Vrioni, Athens, Greece
- Theoklis Zaoutis, Philadelphia, PA, USA